Full Text
EE197 Cost-Effectiveness Analysis of Trastuzumab Emtansine Versus Pertuzumab with Trastuzumab for Chinese Patients with Residual Invasive HER2-Positive Early Breast Cancer

Abstract

Authors

X Guan HC Li Y Xia Q Yang AX Ma

Back to Volume 25, Supplemental Issue 7S
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×